Sermo’s new report explores the tension between GLP-1 efficacy and access. Discover how PBMs and…
What doctors really think about the cost of weight loss drugs
What do doctors think about the cost of weight loss drugs? Learn how cost, access,…
85% of physicians say RNA-based drug Lepodisiran could be a game-changer
Physicians weigh in on Lepodisiran, an RNA-based drug that slashes stealth cholesterol (Lp(a)) by 94%.…
Approaching antibiotic resistance with urgency
Antibiotic resistance is a growing threat. Discover how physicians are responding to antimicrobial challenges.
The rise in Ozempic: What physicians should know
Understand the rise of Ozempic in healthcare, its use among children, drug access, and how…
Neoadjuvant therapies for breast cancer: Key takeaways for physicians
How are physicians using neoadjuvant therapy in breast cancer cases? Read expert analysis and latest…
